GO:0008654 phospholipid biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008654 phospholipid biosynthetic process describes the chemical reactions and pathways that produce phospholipids, the major structural and signaling lipids of cellular membranes.
• Phospholipid biosynthesis is essential for membrane biogenesis, lipid signaling, and organelle identity, and its disruption is linked to cancer, neurodegeneration, and metabolic disease [1, 2].
• Key enzymes include PCYT1A, PCYT2, CHKA, CHKB, PEMT, PISD, and phospholipid transfer proteins such as PITPNA and STARD7 [1, 5, 8].
• Phospholipid synthesis occurs mainly at the endoplasmic reticulum and mitochondria-associated membranes, with transport to other organelles via vesicular and non-vesicular mechanisms [1, 5].
• CRISPR knockout, point-mutation, knock-in, and overexpression models are powerful tools to dissect phospholipid biosynthetic gene function and disease relevance [2, 6].
• Understanding phospholipid biosynthesis informs therapeutic strategies in cancer, neurodegeneration, and rare metabolic disorders [1, 2, 7].
Description
Phospholipids are fundamental components of all cellular membranes, providing structural integrity, defining organelle identity, and serving as precursors for signaling molecules. The Gene Ontology term GO:0008654, phospholipid biosynthetic process, encompasses the chemical reactions and pathways that generate phospholipids, including phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol (PI), and cardiolipin [1, 4]. This process is essential for membrane biogenesis, cell growth, and homeostasis, and its dysregulation is implicated in a wide range of human diseases, from cancer to neurodegeneration [1, 2]. Researchers study phospholipid biosynthesis to understand membrane dynamics, lipid signaling, and the molecular basis of lipid-related disorders [5, 6]. The pathway involves coordinated enzymatic reactions across multiple organelles, with the endoplasmic reticulum (ER) and mitochondria being central hubs [1, 5]. Advances in CRISPR gene editing and lipidomics now enable precise interrogation of individual biosynthetic enzymes and their contributions to cellular physiology and disease [2, 7].
phospholipid biosynthetic process At A Glance
| GO ID | GO:0008654 |
|---|---|
| GO term | phospholipid biosynthetic process |
| Ontology | biological_process |
| Synonym | phospholipid anabolism; phospholipid biosynthesis; phospholipid formation; phospholipid synthesis |
| Major function | Synthesis of phospholipids for membrane biogenesis, lipid signaling, and organelle identity |
| Key enzymes | PCYT1A, PCYT2, CHKA, CHKB, PEMT, PISD, CDS1, CDS2, PLD1, PLD2 |
| Subcellular location | Endoplasmic reticulum, mitochondria-associated membranes, Golgi, mitochondria |
| Regulation | Transcriptional, post-translational, and lipid-mediated feedback; influenced by nutrient status and growth signals |
| Disease relevance | Cancer, neurodegeneration, metabolic disorders, ferroptosis sensitivity |
What Is GO:0008654?
GO:0008654 phospholipid biosynthetic process is defined as the chemical reactions and pathways resulting in the formation of a phospholipid, a lipid containing phosphoric acid as a mono- or diester. This biological process includes the synthesis of all phospholipid classes, such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, and cardiolipin, through enzymatic steps that occur primarily at the endoplasmic reticulum and mitochondria-associated membranes [1, 5]. The term also covers the transport and remodeling steps required to distribute phospholipids to their target membranes [1, 6].
Why Is phospholipid biosynthetic process Important in Cell Biology?
Phospholipid biosynthesis is essential for maintaining membrane integrity, supporting cell proliferation, and enabling signal transduction. Dysregulation of this process contributes to cancer progression, neurodegeneration, and metabolic diseases, making it a critical area of biomedical research [1, 2]. Understanding the enzymes and pathways involved provides opportunities for therapeutic intervention and biomarker discovery [5, 7].
• Provides structural components for all cellular membranes.
• Supports cell growth and division by supplying membrane lipids.
• Generates lipid second messengers such as phosphatidic acid and diacylglycerol.
• Maintains organelle identity and membrane curvature.
• Linked to cancer cell proliferation and survival.
• Implicated in neurodegeneration and membrane trafficking defects [1, 5].
• Modulates ferroptosis sensitivity through lipid composition.
• Required for lipoprotein secretion and lipid transport.
• Target for antiviral and antimicrobial strategies.
• Enables synthetic biology approaches to engineer membrane properties.
What Happens During phospholipid biosynthetic process?
Initiation at the Endoplasmic Reticulum
In simple terms: The process starts in the endoplasmic reticulum, where enzymes assemble the basic phospholipid backbone.
Phospholipid biosynthesis begins at the endoplasmic reticulum (ER) membrane, where glycerol-3-phosphate is acylated to form phosphatidic acid (PA), the central intermediate. PA is then converted to diacylglycerol (DAG) or CDP-DAG, branching into different phospholipid classes. Key enzymes such as GPAT, AGPAT, and phosphatidate phosphatase catalyze these early steps.
Synthesis of Major Phospholipid Classes
In simple terms: Different enzymes build phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and phosphatidylinositol from shared intermediates.
The Kennedy pathway generates phosphatidylcholine (PC) and phosphatidylethanolamine (PE) through choline and ethanolamine intermediates, involving CHKA, CHKB, PCYT1A, PCYT2, and CEPT1. Phosphatidylserine (PS) is synthesized by PS synthases and can be decarboxylated to PE in mitochondria. Phosphatidylinositol (PI) is produced from CDP-DAG and myo-inositol by PISD. Cardiolipin is synthesized in mitochondria from PA and CDP-DAG.
Remodeling and Maturation
In simple terms: After initial synthesis, phospholipids are modified to achieve the right fatty acid composition and membrane properties.
Phospholipids undergo deacylation and reacylation cycles mediated by phospholipases and acyltransferases, such as PLA2 and LPCAT, to generate mature species with specific acyl chains. This remodeling is critical for membrane fluidity, curvature, and protein interactions.
Transport and Distribution
In simple terms: Newly made phospholipids are moved to other organelles where they are needed.
Phospholipid transport occurs via vesicular trafficking and non-vesicular mechanisms involving lipid transfer proteins such as PITPNA, STARD7, and ORP family members [1, 5]. Mitochondria-associated membranes (MAMs) facilitate lipid exchange between ER and mitochondria. Phospholipid flippases maintain asymmetric distribution across the bilayer.
Integration with Membrane Protein Folding
In simple terms: Phospholipids help membrane proteins fold and insert correctly.
Phospholipids assist in membrane protein folding and topogenesis, influencing the insertion and orientation of transmembrane domains. Specific phospholipids such as PE and PG are required for optimal activity of certain membrane proteins.
Key Genes Involved in GO:0008654 phospholipid biosynthetic process
The following genes encode key enzymes and transfer proteins involved in phospholipid biosynthetic process, with established roles in membrane biogenesis and disease.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PCYT1A | CTP:phosphocholine cytidylyltransferase alpha; rate-limiting enzyme in PC synthesis | Mutations cause lipodystrophy and neurodegeneration; target for cancer metabolism studies |
| PCYT2 | CTP:phosphoethanolamine cytidylyltransferase; rate-limiting enzyme in PE synthesis | Linked to hereditary spastic paraplegia; regulates mitochondrial function |
| CHKA | Choline kinase alpha; phosphorylates choline in PC synthesis | Overexpressed in cancer; target for anticancer therapy |
| CHKB | Choline kinase beta; muscle-specific choline kinase | Mutations cause muscular dystrophy with mitochondrial structural abnormalities |
| PEMT | Phosphatidylethanolamine N-methyltransferase; converts PE to PC | Deficiency leads to steatohepatitis and liver failure; involved in lipoprotein metabolism |
| PISD | Phosphatidylserine decarboxylase; converts PS to PE in mitochondria | Mutations cause spondyloepimetaphyseal dysplasia; essential for mitochondrial function |
| CDS1 | CDP-diacylglycerol synthase 1; synthesizes CDP-DAG for PI and PG synthesis | Regulates PI signaling and membrane trafficking |
| CDS2 | CDP-diacylglycerol synthase 2; synthesizes CDP-DAG | Required for PI synthesis and Golgi function |
| PLD1 | Phospholipase D1; hydrolyzes PC to PA | Involved in cancer, autophagy, and membrane trafficking |
| PLD2 | Phospholipase D2; hydrolyzes PC to PA | Regulates cell proliferation and migration |
| PITPNA | Phosphatidylinositol transfer protein alpha; transfers PI and PC between membranes | Essential for PI signaling and vesicle trafficking |
| STARD7 | StAR-related lipid transfer domain protein 7; transfers PC to mitochondria | Required for mitochondrial membrane integrity and function |
| CEPT1 | Choline/ethanolamine phosphotransferase 1; synthesizes PC and PE | Regulates lipid droplet formation and lipoprotein secretion |
| LPCAT1 | Lysophosphatidylcholine acyltransferase 1; remodels PC | Overexpressed in cancer; affects membrane fluidity |
| LPCAT3 | Lysophosphatidylcholine acyltransferase 3; remodels PC and PE | Regulates ferroptosis sensitivity and lipid metabolism |
| MBOAT7 | Membrane-bound O-acyltransferase 7; remodels PI | Associated with fatty liver disease and neurodevelopmental disorders |
| PLA2G6 | Phospholipase A2 group VI; hydrolyzes phospholipids | Mutations cause neurodegeneration with brain iron accumulation |
| ABCA1 | ATP-binding cassette transporter A1; transports phospholipids and cholesterol | Deficiency causes Tangier disease and HDL deficiency |
How Is phospholipid biosynthetic process Regulated?
Phospholipid biosynthetic process is regulated at multiple levels, including transcriptional control by sterol regulatory element-binding proteins (SREBPs) and liver X receptors (LXRs), post-translational modification of rate-limiting enzymes such as PCYT1A, and feedback inhibition by end products. Nutrient status, growth factor signaling, and cellular stress influence flux through the pathway. Phospholipid composition also modulates ferroptosis sensitivity, linking lipid regulation to cell death pathways.
phospholipid biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PCYT1A | Lipodystrophy, neurodegeneration | Knockout and point-mutation cell models |
| PCYT2 | Hereditary spastic paraplegia | Knock-in of patient mutations in iPSCs |
| CHKA | Cancer proliferation | Overexpression and knockout in cancer cell lines |
| PEMT | Steatohepatitis, liver failure | Liver-specific knockout mice |
| PLA2G6 | Neurodegeneration with brain iron accumulation | Knockout and point-mutation models |
Cancer
Altered phospholipid biosynthesis supports rapid cancer cell proliferation by providing membranes and signaling lipids. Overexpression of CHKA and PLD1 is observed in multiple cancers and correlates with poor prognosis. Lipid composition changes can also alter ferroptosis sensitivity, offering therapeutic opportunities.
Neurodegeneration
Defects in phospholipid synthesis and transport contribute to neurodegenerative diseases such as hereditary spastic paraplegia and neurodegeneration with brain iron accumulation [1, 5]. Mutations in PCYT2 and PLA2G6 impair membrane homeostasis and mitochondrial function.
Metabolic and Liver Disorders
PEMT deficiency causes steatohepatitis and liver failure, while MBOAT7 variants are associated with fatty liver disease. Disrupted phospholipid metabolism affects lipoprotein secretion and lipid storage.
Muscular Dystrophy
CHKB mutations lead to muscular dystrophy with mitochondrial structural abnormalities, highlighting the importance of phospholipid synthesis in muscle function.
From phospholipid biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PCYT1A impair membrane biogenesis? | CRISPR knockout in HeLa or HEK293 cells |
| How does a patient mutation in PCYT2 affect enzyme activity? | Point-mutation knock-in via CRISPR |
| Can overexpression of CHKA drive cancer cell proliferation? | CRISPR overexpression in cancer cell lines |
| Where does STARD7 localize and transfer PC? | Tagged knock-in with fluorescent protein |
| What genes regulate ferroptosis sensitivity via phospholipids? | CRISPR library screening with lipid modulators |
| How does PEMT deficiency alter liver lipidomics? | Liver-specific knockout mouse model |
How to Study the phospholipid biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS) | Phospholipid species and abundance | Profiling changes in knockout or overexpression cells |
| Fluorescence microscopy | Subcellular localization and dynamics | Tracking lipid transport and organelle contact sites |
| CRISPR knockout screening | Gene essentiality and pathway regulation | Identifying modifiers of ferroptosis and lipid metabolism |
| Enzyme activity assay | Catalytic activity of biosynthetic enzymes | Validating point mutations and inhibitors |
| RNA-seq | Transcriptional changes in lipid genes | Assessing pathway regulation |
| Proteomics | Protein expression and interactions | Mapping phospholipid enzyme complexes |
| Metabolic labeling | Flux through biosynthetic pathways | Measuring synthesis rates of phospholipids |
| Co-immunoprecipitation | Protein-protein interactions | Identifying lipid transfer protein complexes |
Lipidomics and Mass Spectrometry
Mass spectrometry-based lipidomics quantifies phospholipid species and reveals changes in composition upon genetic perturbation [1, 6]. This method is essential for validating CRISPR models and identifying lipid biomarkers.
Fluorescence Imaging and Live-Cell Tracking
Fluorescently tagged lipid-binding domains and biosensors enable real-time visualization of phospholipid distribution and dynamics in live cells. Imaging of ER and mitochondria markers reveals transport defects.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout or activation screens identify genes that regulate phospholipid biosynthesis and ferroptosis sensitivity. These screens link lipid pathways to cell death and proliferation.
Biochemical Enzyme Assays
In vitro enzyme assays using radiolabeled substrates measure the activity of phospholipid biosynthetic enzymes such as PCYT1A and CHKA. These assays validate the functional impact of mutations.
How CRISPR Can Be Used to Study GO:0008654 phospholipid biosynthetic process
Knockout
CRISPR knockout of phospholipid biosynthetic genes such as PCYT1A, CHKA, or PISD enables researchers to assess their essentiality and impact on membrane composition [1, 2]. Knockout cell lines are valuable for lipidomics and proliferation assays.
Point Mutation
Introducing patient-specific point mutations (e.g., in PCYT2 or PLA2G6) via CRISPR base editing or homology-directed repair allows functional dissection of disease variants. These models reveal how single amino acid changes affect enzyme activity and membrane homeostasis.
Knock-in
Knock-in of fluorescent or affinity tags (e.g., GFP-STARD7) enables live-cell imaging and proteomic analysis of phospholipid transfer proteins [5, 6]. Tagged knock-in models preserve endogenous regulation and localization.
Overexpression
CRISPR activation or cDNA overexpression of genes like CHKA or PLD1 drives excess phospholipid synthesis, modeling cancer-associated lipid reprogramming [1, 2]. Overexpression models are useful for drug screening and pathway analysis.
How EDITGENE Supports phospholipid biosynthetic process Research
Researchers studying phospholipid biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in membrane biogenesis, lipid signaling, or disease. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for functional validation.
Contact EDITGENE today to design your custom CRISPR model for phospholipid biosynthetic process research.
Frequently Asked Questions About phospholipid biosynthetic process
What is phospholipid biosynthetic process?
It is the biological process defined by GO:0008654 that includes all chemical reactions and pathways resulting in the formation of phospholipids, essential for membrane structure and signaling.
What genes are involved in phospholipid biosynthetic process?
Key genes include PCYT1A, PCYT2, CHKA, CHKB, PEMT, PISD, CDS1, CDS2, PLD1, PLD2, PITPNA, STARD7, CEPT1, LPCAT1, LPCAT3, MBOAT7, PLA2G6, and ABCA1 [1, 5, 8].
Where does phospholipid biosynthesis occur in the cell?
It occurs primarily at the endoplasmic reticulum and mitochondria-associated membranes, with transport to other organelles [1, 5].
How is phospholipid biosynthesis regulated?
It is regulated by transcription factors such as SREBPs and LXRs, post-translational modifications, and feedback inhibition by lipid products.
What diseases are linked to phospholipid biosynthesis defects?
Diseases include cancer, neurodegeneration, hereditary spastic paraplegia, muscular dystrophy, and fatty liver disease [1, 2].
How can CRISPR be used to study phospholipid biosynthesis?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional analysis of biosynthetic enzymes and their roles in disease [2, 6].
What methods are used to measure phospholipid biosynthesis?
Lipidomics, mass spectrometry, fluorescence imaging, enzyme assays, and CRISPR screens are commonly used [1, 6].
What is the role of PCYT1A in phospholipid synthesis?
PCYT1A is the rate-limiting enzyme in phosphatidylcholine synthesis and is linked to lipodystrophy and neurodegeneration.
How does phospholipid composition affect ferroptosis?
Lipid composition alters ferroptosis sensitivity, with certain phospholipids promoting or inhibiting lipid peroxidation.
Can phospholipid biosynthesis be targeted therapeutically?
Yes, enzymes like CHKA and PLD1 are being explored as targets in cancer and metabolic diseases [1, 2].
Conclusion
GO:0008654 phospholipid biosynthetic process is a fundamental biological pathway required for membrane biogenesis, lipid signaling, and cellular homeostasis. Its dysregulation contributes to cancer, neurodegeneration, and metabolic disorders, making it a critical research area [1, 2]. Advances in CRISPR gene editing and lipidomics provide powerful tools to dissect the molecular mechanisms and identify therapeutic targets [2, 6]. EDITGENE offers comprehensive CRISPR services to support functional studies of phospholipid biosynthetic genes, accelerating discovery in this important field.
References
- 1. Vance JE. 2015. Phospholipid synthesis and transport in mammalian cells.. Traffic 16(1):1-18 PMID: 25243850
- 2. Park VS et al.. 2025. Lipid Composition Alters Ferroptosis Sensitivity.. Cancer Res 85(22):4380-4397 PMID: 40911781
- 3. Devaux PF. 1988. Phospholipid flippases.. FEBS Lett 234(1):8-12 PMID: 3292284
- 4. McMurray WC et al.. 1972. Phospholipid metabolism.. Annu Rev Biochem 41(10):129-60 PMID: 4570957
- 5. Tamura Y et al.. 2014. Phospholipid transport via mitochondria.. Traffic 15(9):933-45 PMID: 24954234
- 6. Yang Y et al.. 2018. Phospholipid subcellular localization and dynamics.. J Biol Chem 293(17):6230-6240 PMID: 29588369
- 7. Dowhan W et al.. 2019. Lipid-Assisted Membrane Protein Folding and Topogenesis.. Protein J 38(3):274-288 PMID: 30937648
- 8. Dowhan W. 1991. Phospholipid-transfer proteins.. Curr Opin Cell Biol 3(4):621-5 PMID: 1772656
